Arcus Capital Partners’s 2ndVote Life Neutral Plus ETF LYFE Stock Holding History
Bought
Maintained
Sold
Other funds holding LYFE
BTI
SFG
HI
WP
Arcus Capital Partners's LYFE Position: Q1 2023 in Review
Arcus Capital Partners sold out of 2ndVote Life Neutral Plus ETF (LYFE) in Q1 2023, closing a stake of 1,671 shares — an estimated $48.5K sold.
Arcus Capital Partners first reported a position in LYFE in Q4 2022 and held it in 1 quarter. The position peaked at $48.5K in Q4 2022. 11 funds tracked by Wall St. Rank hold LYFE as of Q1 2023.
- Arcus Capital Partners reported no remaining 2ndVote Life Neutral Plus ETF position as of Q1 2023 after selling out during the quarter.
- Arcus Capital Partners sold 1,671 2ndVote Life Neutral Plus ETF shares in Q1 2023, an estimated $48.5K.
- Arcus Capital Partners first reported a position in 2ndVote Life Neutral Plus ETF in Q4 2022 and held it in 1 quarter.
- Arcus Capital Partners's 2ndVote Life Neutral Plus ETF position peaked at $48.5K in Q4 2022.
- 11 funds tracked by Wall St. Rank held 2ndVote Life Neutral Plus ETF as of Q1 2023.
Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.